EVAX
HEALTHCAREEvaxion Biotech A/S
$4.41+0.01 (+0.23%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving EVAX Today?
No stock-specific AI insight has been generated for EVAX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.46$12.15
$4.41
Fundamentals
Market Cap$37M
P/E Ratio—
EPS$-1.00
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-1.0%
Debt / Equity—
Trading
Volume9K
Avg Volume (10D)—
Shares Outstanding8.3M
EVAX News
20 articles- European Equities Traded in the US as American Depositary Receipts Rise FridayYahoo Finance·May 8, 2026
- Evaxion (EVAX) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- Evaxion announces business update and first quarter 2026 financial resultsYahoo Finance·May 7, 2026
- Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026Yahoo Finance·May 4, 2026
- Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating OfficerGlobeNewswire Inc.·Apr 27, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Friday TradingYahoo Finance·Apr 24, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday TradingYahoo Finance·Apr 22, 2026
- European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday TradingYahoo Finance·Apr 21, 2026
- Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trialYahoo Finance·Apr 17, 2026
- New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastomaGlobeNewswire Inc.·Apr 17, 2026
- Evaxion concludes Annual General MeetingYahoo Finance·Apr 16, 2026
- European Equities Traded in the US as American Depositary Receipts Declining in Thursday TradingYahoo Finance·Apr 16, 2026
- European Equities Traded in the US as ADRs Rise in Tuesday TradingYahoo Finance·Apr 14, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday TradingYahoo Finance·Apr 13, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Thursday TradingYahoo Finance·Apr 9, 2026
- European Equities Traded in the US as American Depositary Receipts Surge in Wednesday TradingYahoo Finance·Apr 8, 2026
- Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01GlobeNewswire Inc.·Apr 7, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingYahoo Finance·Mar 31, 2026
- Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine CongressGlobeNewswire Inc.·Mar 30, 2026
- European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday TradingYahoo Finance·Mar 25, 2026
All 20 articles loaded
Price Data
Open$4.43
Previous Close$4.40
Day High$4.60
Day Low$4.31
52 Week High$12.15
52 Week Low$1.46
52-Week Range
$1.46$12.15
$4.41
Fundamentals
Market Cap$37M
P/E Ratio—
EPS$-1.00
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-1.0%
Debt / Equity—
Trading
Volume9K
Avg Volume (10D)—
Shares Outstanding8.3M
About Evaxion Biotech A/S
Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company is headquartered in Hoersholm, Denmark.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—